For the first time, Penetrium™ has been shown to structurally overcome this barrier. Correcting 80 Years ... cell access—providing a fundamental solution to the cold tumor problem.

CHICAGO, May 7, 2025 /PRNewswire/ -- Hyundai Bioscience presented the results of its Penetrium™ combination preclinical studies at the 2025 American Association for Cancer Research (AACR) Annual ...